WALTHAM, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company developing therapies to treat central nervous system (CNS) ...
Technology:The company has developed the Minerva Endometrial Ablation System to treat the problem of heavy menstruation in women who are pre-menopausal and do not wish to have more children. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results